These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2444793)

  • 41. Comparative electrophysiologic effects of metabolites of quinidine and hydroquinidine.
    Fautrez VM; Adamantidis MM; Caron JF; Libersa CC; Dupuis BA
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):308-18. PubMed ID: 1378107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophysiological effects of 5-hydroxypropafenone on guinea pig ventricular muscle fibers.
    Valenzuela C; Delgado C; Tamargo J
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):523-9. PubMed ID: 2447400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: electrophysiologic observations in isolated canine and rabbit cardiac muscle.
    Takanaka C; Singh BN
    Am Heart J; 1990 May; 119(5):1050-60. PubMed ID: 2330863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.
    Szél T; Koncz I; Jost N; Baczkó I; Husti Z; Virág L; Bussek A; Wettwer E; Ravens U; Papp JG; Varró A
    Eur J Pharmacol; 2011 Jul; 662(1-3):31-9. PubMed ID: 21550338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of CM7857, a derivative of disopyramide, on electrophysiologic properties of canine Purkinje fibers and inotropic properties of canine ventricular muscle.
    Endou K; Yamamoto H; Sato T; Nakata F
    J Cardiovasc Pharmacol; 1986; 8(3):507-13. PubMed ID: 2425165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs.
    Osadchii OE
    J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue.
    Damiano BP; Brannan MD
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of amiodarone on repolarization and refractoriness of cardiac fibers.
    Varró A; Nakaya Y; Elharrar V; Surawicz B
    Eur J Pharmacol; 1988 Sep; 154(1):11-8. PubMed ID: 3181292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrophysiological actions of flecainide in normal and infarcted canine Purkinje fibers.
    Kinnaird AA; Lederman CL; Man RY
    Eur J Pharmacol; 1985 May; 112(1):57-64. PubMed ID: 4018138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles.
    Hattori Y; Hidaka T; Aisaka K; Satoh F; Ishihara T
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):407-12. PubMed ID: 2453743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion.
    Faivre JF; Forest MC; Gout B; Bril A
    Eur J Pharmacol; 1999 Oct; 383(2):215-22. PubMed ID: 10585537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S; Bailey JC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological effects of bethanidine sulfate on canine cardiac Purkinje fibers and ventricular muscle cells.
    Dangman KH; Miura DS
    J Cardiovasc Pharmacol; 1985; 7(1):50-8. PubMed ID: 2580150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues.
    Steinberg MI; Wiest SA
    J Cardiovasc Pharmacol; 1984; 6(4):614-21. PubMed ID: 6206315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.